Research and manufacturing of biosimilars in Spain must be encouraged to boost innovation and competition

BioSim News

April 2th 2022BioSim News

encarnacion cruz, CEO of BioSim, explains in a video-interview with PharmaMarket what are the objectives of the Association and the current situation of biosimilar medicines in the Spanish health field.

READ MORE

recently published

Post thumb
Informative breakfasts "Study on the market of biosimilar medicines in the National Health System in Spain"
March 18 2024
Post thumb
Horizon scanning
Jan 31 2024
Post thumb
Early Treatment: the role of biosimilars
18 2023 December
Post thumb
Study on the market for biosimilar medicines in the National Health System in Spain 2016-2022
18 2023 December

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE